Abstract

Two-component signaling systems (TCSs) are major mechanisms by which bacteria adapt to environmental conditions. It follows then that TCSs would play important roles in the adaptation of pathogenic bacteria to host environments. However, no pathogen-associated TCS has been identified in uropathogenic Escherichia coli (UPEC). Here, we identified a novel TCS, which we termed KguS/KguR (KguS: α-ketoglutarate utilization sensor; KguR: α-ketoglutarate utilization regulator) in UPEC CFT073, a strain isolated from human pyelonephritis. kguS/kguR was strongly associated with UPEC but was found only rarely among other E. coli including commensal and intestinal pathogenic strains. An in vivo competition assay in a mouse UTI model showed that deletion of kguS/kguR in UPEC CFT073 resulted in a significant reduction in its colonization of the bladders and kidneys of mice, suggesting that KguS/KguR contributed to UPEC fitness in vivo. Comparative proteomics identified the target gene products of KguS/KguR, and sequence analysis showed that TCS KguS/KguR and its targeted-genes, c5032 to c5039, are encoded on a genomic island, which is not present in intestinal pathogenic E. coli. Expression of the target genes was induced by α-ketoglutarate (α-KG). These genes were further shown to be involved in utilization of α-KG as a sole carbon source under anaerobic conditions. KguS/KguR contributed to the regulation of the target genes with the direct regulation by KguR verified using an electrophoretic mobility shift assay. In addition, oxygen deficiency positively modulated expression of kguS/kguR and its target genes. Taken altogether, this study describes the first UPEC-associated TCS that functions in controlling the utilization of α-ketoglutarate in vivo thereby facilitating UPEC adaptation to life inside the urinary tract.

Highlights

  • Urinary tract infection (UTI) is one of the most common bacterial infections in humans and is a significant clinical issue worldwide

  • Though many Two-component signaling systems (TCSs) that have been characterized in commensal E. coli have been associated with uropathogenic Escherichia coli (UPEC) pathogenesis, no characterized TCS has been significantly associated with UPEC strains

  • This novel TCS and its target genes were involved in anaerobic utilization of a-ketoglutarate, an abundant metabolite in UPEC infection site-renal proximal tubules, contributed to UPEC fitness in vivo

Read more

Summary

Introduction

Urinary tract infection (UTI) is one of the most common bacterial infections in humans and is a significant clinical issue worldwide. 80–90% of community-acquired UTIs are caused by uropathogenic Escherichia coli (UPEC) [2]. Many virulence factors are required for UPEC to cause UTIs. Typically, UTIs begin with urethral contamination with UPEC from the bowel [3]. UPEC may ascend the urethra to enter the bladder and kidneys, where several highly regulated virulence factors, including fimbriae, secreted toxins (hemolysin, Vat, Sat, and CNF) and polysaccharide capsule, may contribute to colonization and pathogenesis [6]. It is likely that UPEC’s ability to colonize the urinary tract and cause disease is affected by its adaptive responses to local environmental cues, including changes in nutrient availability

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.